Eupraxia Pharmaceuticals Inc. (EPRX) stock
EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.62−0.72 (-9.81%)
Close on Nov 17, 2026Market cap $399.15MP/E –Yield –
Eupraxia Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Eupraxia Pharmaceuticals's price to book ratio was 5.1× on Nov 11, 2026, against 6.6× a year earlier. Over the last 4 years it ranged from 3.5× to 61.7×, with a median of 8.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.1× | −3.0 |
| 2025 | Dec 31, 2025 | 8.1× | −31.0 |
| 2024 | Dec 31, 2024 | 39.0× | +27.5 |
| 2023 | Dec 29, 2023 | 11.5× | – |
See a number that looks wrong?